Gastroenterology Research and Practice / 2009 / Article / Tab 1 / Clinical Study
Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function Table 1 Patient characteristics at baseline.
Patient ID Gender/age (years)/diagnosis Body mass index (kg/m2 ) Small bowel (cm) Colon-in cont. (%) Time since last surgery (years) Wet weight intake (kg/d) Fecal wet weight excretion (kg/d) Parenteral fluid (L/d) Diet energy intake (MJ/d) Fecal energy excretion (MJ/d) Patenteral energy (MJ/d) Duration of HPN (years) Time on GLP-2(days,
2 years) HRM F/47/CD
0.8 2.5
LM M/27/CD
6.4 2.5
OB M/49/CD
0.0 11.6
Abd. painGL M/53/CD
no no
JP M/24/CD
Abd. painEFP F/55/CD
unrel. feedbackJE M/44/UC compl.
no no
JHJ M/55/UC compl.
UDJ F/50/UC compl.
JV M/67/CD
no no
FVL M/59/CD
no no
M: male, F: female, CD: Crohns disease, UC compl.: Ulcerative colitis complications, Abd. Pain: Abdominal pain, Unrel. Feedback: Unreliable feedback.